Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Authors:
Open Access
- 10 June 2025
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (6) , 102188
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Ambrose Monell Foundation
- National Institutes of Health National Cancer Institute
- Swiss National Science Foundation
This publication has 141 references indexed in Scilit:
- CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomibBlood, 2008
- DNA‐damage response control of E2F7 and E2F8EMBO Reports, 2008
- Characterisation and protein expression profiling of annexins in colorectal cancerBritish Journal of Cancer, 2007
- Macrophage Migration Inhibitory Factor: A Probable Link between Inflammation and CancerImmunity, 2007
- SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma DevelopmentCancer Research, 2006
- Thy‐1 as a regulator of cell‐cell and cell‐matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosisThe FASEB Journal, 2006
- Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesisGut, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Human Thy-1 (CD90) on Activated Endothelial Cells Is a Counterreceptor for the Leukocyte Integrin Mac-1 (CD11b/CD18)The Journal of Immunology, 2004
- Esophageal CancerNew England Journal of Medicine, 2003